文献速递银屑病与炎症性皮肤病

PCSK9对银屑病样炎症的促进作用

Potentiation of Psoriasis-Like Inflammation by PCSK9.
PubMed 文献 · J Invest Dermatol · 2018-11-02

本研究探讨PCSK9在银屑病中的作用及局部应用靶向Pcsk9的小干扰RNA治疗银屑病的潜力。发现PCSK9在银屑病皮损中过表达,抑制Pcsk9可减轻咪喹莫特诱导的炎症反应并抑制角质形成细胞过度增殖,抑制PCSK9可显著改变细胞周期并诱导人角质形成细胞凋亡。提示PCSK9在银屑病中起重要作用,可能是一个治疗靶点。

要点

  • PCSK9在银屑病皮损中过表达。
  • 抑制Pcsk9可减轻咪喹莫特诱导的小鼠炎症反应并抑制角质形成细胞过度增殖。
  • 抑制PCSK9可显著改变细胞周期并诱导人角质形成细胞凋亡。

核心结论

  • PCSK9在银屑病中起重要作用,可能是一个治疗靶点。

研究设计与样本

  • 研究检测了银屑病患者皮损中PCSK9的表达,并使用Pcsk9敲除小鼠和Pcsk9小干扰RNA处理的小鼠研究咪喹莫特诱导的银屑病样反应,同时使用培养的人角质形成细胞研究PCSK9在调节细胞增殖和凋亡中的作用。

主要发现

  • PCSK9在银屑病皮损中过表达。
  • 抑制Pcsk9可减轻咪喹莫特诱导的炎症反应并抑制角质形成细胞过度增殖。
  • 抑制PCSK9可显著改变细胞周期并诱导人角质形成细胞凋亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psoriasis is a systemic inflammatory disease, associated with metabolic disorders, including high level of low-density lipoprotein. PCSK9, which promotes the degradation of low-density lipoprotein receptors and, therefore, the increased concentration of circulating low-density lipoprotein, is also involved in inflammation. This study aims to examine the role of PCSK9 in psoriasis and to investigate the potential of topically applying small interfering RNA targeting Pcsk9 as a psoriasis treatment. We investigated the expression of PCSK9 in lesions of psoriasis patients and imiquimod-induced psoriatic reactions in Pcsk9-knockout and Pcsk9 small interfering RNA-treated mice, and we also used cultured human keratinocytes to investigate the role of PCSK9 in regulating cell proliferation and apoptosis. We found that PCSK9 is overexpressed in psoriatic lesions and that suppressing Pcsk9 can decrease the inflammatory reaction induced by imiquimod treatment and inhibit hyperproliferation of keratinocytes. We also found that suppressing PCSK9 can significantly alter the cell cycle and induce apoptosis of human keratinocytes. Taken together, our findings indicate that PCSK9 plays an important role in psoriasis and may be a therapeutic target.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Luan C, Chen X, Zhu Y, et al. Potentiation of Psoriasis-Like Inflammation by PCSK9. J Invest Dermatol. 2018. PMID: 30395847. doi:10.1016/j.jid.2018.07.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。